Suppr超能文献

肢端肥大症患者甲状腺疾病及甲状腺恶性肿瘤的评估

Evaluation of thyroid disease and thyroid malignancy in acromegalic patients.

作者信息

Cankurtaran Yılmaz, Örük Güzide G, Tozduman Büşra

机构信息

Department of Internal Medicine, Atatürk Training and Research Hospital, İzmir Kâtip Çelebi University, İzmir, Türkiye -

Division of Endocrinology and Metabolism, Department of Internal Medicine, Atatürk Training and Research Hospital, İzmir Kâtip Çelebi University, İzmir, Türkiye.

出版信息

Minerva Endocrinol (Torino). 2023 Jun;48(2):130-139. doi: 10.23736/S2724-6507.21.03363-7. Epub 2021 May 14.

Abstract

BACKGROUND

Differences in epidemiological data from different geographical regions have made the prevalence of thyroid disease and thyroid cancer controversial. No previous study has investigated whether thyroid disease and thyroid cancer prevalence are higher in acromegalic patients than in the general population in Türkiye. The aim of this study is to determine the prevalence of thyroid disease and thyroid cancer in acromegaly and to compare it with the control group.

METHODS

A total of 129 acromegalic patients (78 female, 51 male) and 247 control group patients (151 female, 96 male) were included in the study. Pituitary size, growth hormone (GH) and insulin-like growth factor (IGF)-1 levels in all patients with acromegaly and thyroid function tests, thyroid receptor autoantibody (TRAb), thyroid scintigraphy, thyroid ultrasonography (US), fine-needle aspiration cytology (FNAC) and histopathology findings after thyroidectomy were recorded.

RESULTS

Thyroid lesions were present in 93 patients (72.1%) with acromegaly. While diffuse goiter (14.7%) and multinodular goiter (MNG) (47.3%) were significantly higher, Graves' disease (4.5%) was significantly lower in the acromegaly group compared to control group. The presence of thyroid lesions and thyroid nodules was significantly higher in patients with acromegaly (odds ratio 2.766; 95% CI 2.112-4.469, P<0.001 and OR 1.955; 95% CI 1.206-3.170, P=0.007). According to gender, the prevalence of thyroid lesions, MNG and thyroid cancer was significantly higher in female patients than in the control group. Thyroid cancer prevalence was found in 7% of acromegalic patients and the prevalence of thyroid cancer in the control group was 4.5%.

CONCLUSIONS

It remains controversial whether the risk of thyroid cancer is increased or not in patients with acromegaly. In this study, there is no significant difference in thyroid cancer between acromegaly and control group, but thyroid lesions are significantly more common in acromegaly. Also, more research is required to determine if thyroid lesions are more prevalent in females with acromegaly.

摘要

背景

不同地理区域的流行病学数据差异使得甲状腺疾病和甲状腺癌的患病率存在争议。此前尚无研究调查土耳其肢端肥大症患者中甲状腺疾病和甲状腺癌的患病率是否高于普通人群。本研究的目的是确定肢端肥大症患者中甲状腺疾病和甲状腺癌的患病率,并与对照组进行比较。

方法

本研究共纳入129例肢端肥大症患者(78例女性,51例男性)和247例对照组患者(151例女性,96例男性)。记录所有肢端肥大症患者的垂体大小、生长激素(GH)和胰岛素样生长因子(IGF)-1水平,以及甲状腺功能检查、甲状腺受体自身抗体(TRAb)、甲状腺闪烁显像、甲状腺超声(US)、细针穿刺细胞学检查(FNAC)和甲状腺切除术后的组织病理学结果。

结果

93例(占72.1%)肢端肥大症患者存在甲状腺病变。与对照组相比,肢端肥大症组弥漫性甲状腺肿(14.7%)和多结节性甲状腺肿(MNG)(47.3%)显著更高,而格雷夫斯病(4.5%)显著更低。肢端肥大症患者中甲状腺病变和甲状腺结节的存在显著更高(优势比2.766;95%置信区间2.112 - 4.469,P < 0.001;优势比1.955;95%置信区间1.206 - 3.170,P = 0.007)。按性别划分,女性患者中甲状腺病变、MNG和甲状腺癌的患病率显著高于对照组。7%的肢端肥大症患者发现有甲状腺癌,对照组中甲状腺癌的患病率为4.5%。

结论

肢端肥大症患者甲状腺癌风险是否增加仍存在争议。在本研究中,肢端肥大症组和对照组之间甲状腺癌无显著差异,但肢端肥大症中甲状腺病变明显更常见。此外,需要更多研究来确定甲状腺病变在肢端肥大症女性中是否更普遍。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验